T 0725/05 (Humanized Immunoglobulins II/PDL) of 14.10.2009

European Case Law Identifier: ECLI:EP:BA:2009:T072505.20091014
Date of decision: 14 October 2009
Case number: T 0725/05
Application number: 95105609.2
IPC class: C07K 16/46
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 61.591K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Production of Humanized Immunoglobulins and Corresponding Polynucleotiodies
Applicant name: PDL BioPharma, Inc.
Opponent name: (02) Boehringer Ingelheim GmbH
(03) Medimmune, Inc.
(04) Schering Corporation
(07) Novartis AG
(08) IDEC Pharmaceuticals Corpn
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 76(1)
European Patent Convention Art 111(1)
European Patent Convention Art 112
European Patent Convention Art 114(1)
European Patent Convention R 103(1)(a)
Rules of procedure of the Boards of Appeal Art 12
Rules of procedure of the Boards of Appeal Art 13
Keywords: Substantial procedural violation, remittal, reimbursement of the appeal fee, referral of questions to the EBA - (no)
First auxiliary request - added subject-matter - (yes)
Second auxiliary request - admissibility - (no)


Cited decisions:
T 0011/82
T 0473/98
T 0500/01
T 0900/02
Citing decisions:
T 2238/11

10 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: IV Divisional Applications

General Case Law